For the year ending 2025-12-31, ETON has $92,114K in assets. $65,960K in debts. $25,942K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 25,942 | |||
| Accounts receivable, net | 11,757 | |||
| Inventories, net | 15,419 | |||
| Prepaid expenses and other current assets | 7,463 | |||
| Total current assets | 60,581 | |||
| Property and equipment, net | 326 | |||
| Intangible assets, net | 30,878 | |||
| Operating lease right-of-use assets, net | 310 | |||
| Other long-term assets, net | 19 | |||
| Total assets | 92,114 | |||
| Accounts payable | 10,976 | |||
| Current portion of long-term debt, net of discount | 8,789 | |||
| Accrued medicaid rebates | 9,317 | |||
| Accrued liabilities, current | 9,408 | |||
| Total current liabilities | 38,490 | |||
| Long-term debt, net of discount and including accrued fees | 21,769 | |||
| Operating lease liabilities, noncurrent | 460 | |||
| Other long-term liabilities | 5,241 | |||
| Total liabilities | 65,960 | |||
| Common stock, 0.001 par value 50,000,000 shares authorized 27,047,061 and 26,709,084 shares issued and outstanding at december 31, 2025 and 2024, respectively | 27 | |||
| Additional paid-in capital | 138,621 | |||
| Accumulated deficit | -112,494 | |||
| Total stockholders equity | 26,154 | |||
| Total liabilities and stockholders equity | 92,114 | |||
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON)